JSP Pharmaceutical Manufacturing (Thailand) PCL TNRCF
J
JSP Pharmaceutical Manufacturing (Thailand) PCL. Stock Analysis TNRCF
United States N/A Nano Cap JSP Pharmaceutical Manufacturing (Thailand) Public Co. Ltd. operates the business of producing products according to customer needs, producing drugs, dietary supplements, cosmetics, herbs and dietary supplements in the form of vitamins to nourish the body. The company is headquartered in Bangkok, Bangkok Metropolis and currently employs 451 full-time employees. The company went IPO on 2021-11-02. The firm's businesses comprise providing services in production and product distribution under the client's brand (OEM); manufacturing and distributing under the Company's brand (Own Brand); manufacturing and distributing hemodialysis solution; providing services in relation to product research and development, laboratory testing, consulting, training and seminar, and other products. Its brands consist of COX, JSP, Suphap Osot, and EVITON. Its supplement products include 4 Mix Oil, Wolffia Cap, Acerola Cherry, Coconut Oil, and Fish Oil. Its herbal products include Curcuma Longa Capsule Formula 5 (Household Remedy License), and Compound Senna Laxative Capsule (Household Remedy License). Its JSP supplement products include pure collagen peptide and Choco drink.
JSP Pharmaceutical Manufacturing (Thailand) PCL (TNRCF) Chart
Financial Metrics & Statements of JSP Pharmaceutical Manufacturing (Thailand) PCL (TNRCF)
FAQ's for JSP Pharmaceutical Manufacturing (Thailand) PCL (TNRCF)
- As of August 2026, JSP Pharmaceutical Manufacturing (Thailand) PCL TNRCF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes JSP Pharmaceutical Manufacturing (Thailand) PCL using these criteria to determine its compliance status.
- Muslim investors may consider investing in JSP Pharmaceutical Manufacturing (Thailand) PCL if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of JSP Pharmaceutical Manufacturing (Thailand) PCL by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of JSP Pharmaceutical Manufacturing (Thailand) PCL may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of JSP Pharmaceutical Manufacturing (Thailand) PCL on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for JSP Pharmaceutical Manufacturing (Thailand) PCL (TNRCF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
